| Empirical estimation of under-reporting in the US Food and Drug Administration adverse event reporting system (FAERS) YM Alatawi, RA Hansen Expert opinion on drug safety 16 (7), 761-767, 2017 | 129 | 2017 |
| The association between health beliefs and medication adherence among patients with type 2 diabetes YM Alatawi, J Kavookjian, G Ekong, MM Alrayees Research in Social and Administrative Pharmacy 12 (6), 914-925, 2016 | 111 | 2016 |
| Prevalence of post-traumatic stress disorder during the COVID-19 pandemic in Saudi Arabia FS Alshehri, Y Alatawi, BS Alghamdi, AA Alhifany, A Alharbi Saudi Pharmaceutical Journal 28 (12), 1666-1673, 2020 | 80 | 2020 |
| The psychological impact of COVID-19 on healthcare workers in Saudi Arabia: a year later into the pandemic AH Almalki, MS Alzahrani, FS Alshehri, A Alharbi, SF Alkhudaydi, ... Frontiers in Psychiatry 12, 797545, 2021 | 44 | 2021 |
| Comparison of brand versus generic antiepileptic drug adverse event reporting rates in the US Food and Drug Administration Adverse Event Reporting System (FAERS) MM Rahman, Y Alatawi, N Cheng, J Qian, AV Plotkina, PL Peissig, ... Epilepsy research 135, 71-78, 2017 | 25 | 2017 |
| Perception of threat and psychological impact of COVID-19 among expatriates in Makkah Region, Saudi Arabia MA Algarni, MS Alzahrani, Y Alatawi, RA Alasmari, HO Alsaab, ... International Journal of Environmental Research and Public Health 18 (12), 6650, 2021 | 18 | 2021 |
| Melatonin improves short-term spatial memory in a mouse model of Alzheimer’s disease S Labban, FS Alshehri, M Kurdi, Y Alatawi, BS Alghamdi Degenerative Neurological and Neuromuscular Disease, 15-27, 2021 | 18 | 2021 |
| Psychological distress during COVID-19 curfews and social distancing in Saudi Arabia: a cross-sectional study BS Alghamdi, Y Alatawi, FS Alshehri, HO Tayeb, H AboTaleb, ... Frontiers in Public Health 9, 792533, 2022 | 17 | 2022 |
| Health literacy, perceived threat, and posttraumatic stress disorder during the COVID-19 pandemic in Saudi Arabia Y Alatawi, FS Alshehri, AA Alhifany, A Alharbi, BS Alghamdi Risk management and healthcare policy, 3147-3153, 2020 | 16 | 2020 |
| Evaluation of impact of a pharmacist-led educational campaign on disease knowledge, practices and medication adherence for type-2 diabetic patients: a prospective pre-and post … YH Khan, AI Alzarea, NH Alotaibi, AD Alatawi, A Khokhar, AS Alanazi, ... International Journal of Environmental Research and Public Health 19 (16), 10060, 2022 | 15 | 2022 |
| PD-L1 is highly expressed in ovarian cancer and associated with cancer stem cells populations expressing CD44 and other stem cell markers K Alwosaibai, S Aalmri, M Mashhour, S Ghandorah, A Alshangiti, F Azam, ... BMC cancer 23 (1), 13, 2023 | 13 | 2023 |
| Current situation of medication errors in Saudi Arabia: a nationwide observational study TM Alshammari, KA Alenzi, Y Alatawi, AS Almordi, AF Altebainawi Journal of Patient Safety 18 (2), e448-e453, 2022 | 13 | 2022 |
| Effectiveness and safety of favipiravir compared to hydroxychloroquine for management of covid-19: a retrospective study M Alotaibi, A Ali, D Bakhshwin, Y Alatawi, S Alotaibi, A Alhifany, B Alharthi, ... International Journal of General Medicine, 5597-5606, 2021 | 13 | 2021 |
| Relationship between public mental health and immune status during the COVID-19 pandemic: cross-sectional data from Saudi Arabia BS Alghamdi, Y Alatawi, FS Alshehri, HO Tayeb, FI Tarazi Risk Management and Healthcare Policy, 1439-1447, 2021 | 13 | 2021 |
| Mixed approach retrospective analyses of suicide and suicidal ideation for brand compared with generic central nervous system drugs N Cheng, MM Rahman, Y Alatawi, J Qian, PL Peissig, RL Berg, CD Page, ... Drug safety 41, 363-376, 2018 | 13 | 2018 |
| Association between graduates' factors and success rate on the Saudi Pharmacist Licensure Examination: A single-Institution cross-sectional study AA Alhifany, FA Almalki, YM Alatawi, LA Basindowh, SS Almajnoni, ... Saudi Pharmaceutical Journal 28 (12), 1830-1833, 2020 | 12 | 2020 |
| Brand vs generic adverse event reporting patterns: an authorized generic‐controlled evaluation of cardiovascular medications Y Alatawi, MM Rahman, N Cheng, J Qian, PL Peissig, RL Berg, CD Page, ... Journal of clinical pharmacy and therapeutics 43 (3), 327-335, 2018 | 12 | 2018 |
| Cost-effectiveness of more intensive blood pressure treatment in patients with high risk of cardiovascular disease in Saudi Arabia: a modelling study of meta-analysis Z Almalki, Y Alatawi, A Alharbi, B Almaklefi, S Alfaiz, O Almohana, ... International Journal of Hypertension 2019, 2019 | 11 | 2019 |
| Vit-deit: An ensemble model for breast cancer histopathological images classification A Alotaibi, T Alafif, F Alkhilaiwi, Y Alatawi, H Althobaiti, A Alrefaei, ... 2023 1st International Conference on Advanced Innovations in Smart Cities …, 2023 | 10 | 2023 |
| Methodological considerations for comparison of brand versus generic versus authorized generic adverse event reports in the US Food and Drug Administration Adverse Event … MM Rahman, Y Alatawi, N Cheng, J Qian, PL Peissig, RL Berg, DC Page, ... Clinical drug investigation 37, 1143-1152, 2017 | 10 | 2017 |
Dr. Abdullah A. AlhifanyAssociate Professor of Clinical Pharmacy, College of Pharmacy, Umm Al-Qura UniversityVerified email at uqu.edu.sa
